Some may find one compound controls their glucose better than the other
Orient J Chem 30:12431251
A separate 2025 trial in NEJM Evidence (Shah et al.) in adults with T1D and obesity on AID found that around one in three semaglutide-treated participants met a combined goal of improved time in range, low hypoglycemia, and at least 5% weight loss
IA has received research support from Novo Nordisk, outside the submitted work
Detoxification: Exposure to environmental factors like heavy metals, carcinogens, herbicides, radiation, and more can pollute the body over time and cause steady damage
::: : -1glucagon-like peptide-1 agonists, GLP-1 agonists-4dipeptidyl peptidase-4 inhibitors, DDP-4 inhibitors incretinGLP-1GLP-1GLP-1GLP-1GLP-1DDP-4 exenatide Byetta ,Bydureon ,liraglutide Victoza ,GLP-1Exendin-4Gila monsterGLP-1DDP-4Exenatideexendin-4metforminglitazoneExenatideByetta 5g66010Bydureon 2mgExenatideHbA1CexenatideexenatideLiraglutideGLP-10.61.2-1.8LiraglutideHbA1Cexenatideexenatideexenatide DDP-4GLP-1DDP-4sitagliptinJanuvia ,saxagliptinOnglyza ,linagliptinTrajenta ,vildagliptinGalvus ,4vildagliptinDDP-4HbA1CDDP-4 microvascular disease75162macrovascular disease -incretinDDP-4137-140
